Shawn Anderson, DO
Family Medicine · Meridian, MSNPI 1003831397
Payments from drug & device makers
Across 503 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$989
- Amgen$929
- Lilly USA, LLC$871
- Johnson & Johnson$675
- AbbVie$638
- plus $3K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 84 | $2,323 |
| Novo Nordisk | 62 | $989 |
| Amgen | 49 | $929 |
| Lilly USA, LLC | 65 | $871 |
| Johnson & Johnson | 25 | $675 |
| AbbVie(2 entities) | 48 | $638 |
| Merck | 27 | $415 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $335 |
| Boehringer Ingelheim | 11 | $316 |
| Bayer | 13 | $288 |
| Kowa Pharmaceuticals America, Inc. | 11 | $179 |
| Pfizer | 10 | $178 |
| Avanir Pharmaceuticals, Inc. | 5 | $161 |
| Amarin Pharma, Inc. | 9 | $143 |
| Teva Pharmaceuticals USA, Inc. | 9 | $142 |
| E.r. Squibb & Sons, L.L.C. | 10 | $141 |
| Inspire Medical Systems, Inc. | 1 | $132 |
| Astellas Pharma US Inc | 7 | $102 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $90 |
| Novartis | 5 | $87 |
| Sanofi-aventis U.S. LLC | 4 | $74 |
| Eisai Inc. | 4 | $69 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Arbor Pharmaceuticals, Inc. | 3 | $57 |
| Biohaven Pharmaceuticals, Inc. | 3 | $56 |
| Mylan Specialty L.p. | 2 | $53 |
| Radius Health, Inc. | 3 | $48 |
| Daiichi Sankyo Inc. | 1 | $20 |
| GSK | 1 | $20 |
| Abbott | 1 | $18 |
| Medtronic | 1 | $18 |
| Exact Sciences | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Assertio Therapeutics, Inc. | 1 | $14 |
| Biolase, Inc. | 1 | $9 |
How this compares
$9,685 in reported general payments places this provider in the 90th percentile of 971 family medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Meridian
- Douglas PhillipsMeridian$11K
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
- Alexander OsowaJackson$2.2M
- Russell CarlisleWesson$1.6M
- Kristi TrimmRidgeland$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.